| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 1.04% |
| NAV | ₹25.24 (05 Aug 2020) |
|---|---|
| Fund Started | 24 Feb 2014 |
| Fund Size | ₹1,467 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Coromandel International Ltd. | Chemicals | Equity | 7.5% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 6.8% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 6.7% |
| Endurance Technologies Ltd. | Automobile | Equity | 5.9% |
| Abbott India Ltd. | Healthcare | Equity | 5.4% |
| Hindustan Unilever Ltd. | FMCG | Equity | 5.0% |
| Avenue Supermarts Ltd. | Services | Equity | 4.6% |
| Larsen & Toubro Infotech Ltd. | Technology | Equity | 4.0% |
| RBL Bank Ltd. | Financial | Equity | 3.5% |
| Voltas Ltd. | Cons Durable | Equity | 3.4% |
Motilal Oswal Midcap 30 Fund Direct Growth is a Equity Mutual Fund Scheme launched by Motilal Oswal Mutual Fund. This scheme was made available to investors on 24 Feb 2014. Abhiroop Mukherjee, Akash Singhania, Siddharth Bothra is the Current Fund Manager of Motilal Oswal Midcap 30 Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,467 Cr and the Latest NAV as of 05 Aug 2020 is ₹25.24.
The Motilal Oswal Midcap 30 Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500. Exit load of 1% if redeemed within 15 days
The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality midcap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.